Prevention of human papillomavirus-related diseases: Impediments to progress

Preventive Medicine

Volumn 57, Issue 5, 2013, Pages 407-408

  Zimet, Gregory D ^a   Buffler, Patricia ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cervical cancer; Health communication; Human papillomavirus DNA tests; Human papillomavirus vaccines; Public advocacy; Screening

Indexed keywords

WART VIRUS VACCINE;

CANADA; CASE STUDY; DRUG SAFETY; EDITORIAL; EMPIRICAL RESEARCH; HEALTH CARE MANAGEMENT; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HUMAN; NONHUMAN; PAPILLOMAVIRUS INFECTION; PRACTICE GUIDELINE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PUBLIC HEALTH; SCHOOL; SCREENING; UTERINE CERVIX CANCER; VACCINATION; WART VIRUS;

CERVICAL CANCER; HEALTH COMMUNICATION; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMAN PAPILLOMAVIRUS VACCINES; PUBLIC ADVOCACY; SCREENING;

ATTITUDE OF HEALTH PERSONNEL; CATHOLICISM; COMMUNICATION; CONSUMER ADVOCACY; CROSS-CULTURAL COMPARISON; CULTURE; EARLY DETECTION OF CANCER; FEMALE; HEALTH EDUCATION; HUMANS; MASS VACCINATION; MYTHOLOGY; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PRIMARY HEALTH CARE; PUBLIC HEALTH PRACTICE; RELIGION AND MEDICINE; SCHOOL HEALTH SERVICES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84885699897     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2013.08.005     Document Type: Editorial

References (20)

1. ACOG Committee on Practice Bulletins-Gynecology ACOG practice bulletin no. 109: cervical cytology screening. Obstet. Gynecol. 2009, 114:1409-1420.
2. Ali H., Donovan B., Wand H., Read T.R., Regan D.G., Grulich A.E., Fairley C.K., Guy R.J. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. BMJ 2013, 346:f2032.
3. Baandrup L., Blomberg M., Dehlendorff C., Sand C., Andersen K.K., Kjaer S.K. Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program. Sex. Transm. Dis. 2013, 40:130-135.
4. Catholic Medical Association Catholic Medical Association position paper on HPV immunization (Accessed July 30, 2013). http://www.cathmed.org/assets/files/Position%20Paper%20on%20HPV%20Immunization.pdf.
5. Centers for Disease Control and Prevention Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013 - United States. MMWR 2013, 62:591-595.
6. Colgrove J. The ethics and politics of compulsory HPV vaccination. N. Engl. J. Med. 2006, 355:2389-2391.
7. Field R.I., Caplan A.L. A proposed ethical framework for vaccine mandates: competing values and the case of HPV. Kennedy Inst. Ethics J. 2008, 18:111-124.
8. Guichon J.R., Mitchell I., Buffler P., Caplan A. Citizen intervention in a religious ban on in-school HPV vaccine administration in Calgary, Canada. Prev. Med. 2013, 57(5):409-413. (this issue).
9. Haber G., Malow R.M., Zimet G.D. The HPV vaccine mandate controversy. J. Pediatr. Adolesc. Gynecol. 2007, 20:325-331.
10. Lo B. HPV vaccine and adolescents' sexual activity. BMJ 2006, 332:1106-1107.
11. Markowitz L.E., Hariri S., Lin C., Dunne E.F., Steinau M., McQuillan G., Unger E.R. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Survey, 2003-2010. J Infect Dis 2013, 208:385-393.
12. Rogers E.M. A prospective and retrospective look at the diffusion model. J. Health Commun. 2004, 9(Suppl. 1):13-19.
13. Roland K.B., Benard V.B., Greek A., Hawkins N.A., Manninen D., Saraiya M. Primary care provider practices and beliefs related to cervical cancer screening with the HPV test in Federally Qualified Health Centers. Prev. Med. 2013, 57(5):419-425. (this issue).
14. Saraiya M., Steben M., Watson M., Markowitz L. Evolution of cervical cancer screening and prevention in United States and Canada: Implications for public health practitioners and clinicians. Prev. Med. 2013, 57(5):426-433. (this issue).
15. Saslow D., Runowicz C.D., Solomon D., Moscicki A.B., Smith R.A., Eyre H.J., Cohen C., American Cancer Society American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J. Clin. 2002, 52:342-362.
16. Saslow D., Solomon D., Lawson H.W., Killackey M., Kulasingam S.L., Cain J., Garcia F.A., Moriarty A.T., Waxman A.G., et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J. Clin. 2012, 62:147-172.
17. Schwartz J.L., Caplan A.L., Faden R.R., Sugarman J. Lessons from the failure of human papillomavirus vaccine state requirements. Clin. Pharmacol. Ther. 2007, 82:760-763.
18. Smith R.W., Motiuk D., Henry F.D., Pettipas G., Bouchard L., Chatlain M. Alberta bishops' statement on Gardasil vaccine. Western Catholic Reporter (Accessed July 29, 2013). http://hugyourkids.org/correspondence/HPV%20Alberta%20Bishops'%20Letter.pdf.
19. Thompson A. Human papilloma virus, vaccination and social justice: an analysis of a Canadian school-based vaccine program. Public Health Ethics 2013, 6:11-20.
20. Zimet G.D., Rosberger Z., Fisher W.A., Perez S., Stupiansky N.W. Beliefs, behaviors and HPV vaccine: Correcting the myths and the misinformation. Prev. Med. 2013, 57(5):414-418. (this issue).